NeuroPace (NPCE) Misses Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to NeuroPace (NPCE) Misses Q2 EPS by 7c

NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update

August 11, 2022 4:02 PM EDT

MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported financial results for the quarter ending June 30, 2022.

Recent Highlights

Announced exclusive U.S. distribution agreement with DIXI Medical to sell its stereo EEG electrodes to Epilepsy Monitoring Units (EMUs)Completed sales team expansion initiativeBegins enrollment in the NAUTILUS study for primary generalized epilepsyTotal revenue of $10.2 million for the second quarter of 2022Initial implant... More